Affimed (AFMD) Misses Q1 EPS by 2c

Affimed (NASDAQ: AFMD) reported Q1 EPS of (EUR0.21), EUR0.02 worse than the analyst estimate of (EUR0.19). Revenue for the quarter came in at EUR4.51 million versus the consensus estimate of EUR5.63 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Nucor projects Q3 2026 earnings above prior year, below estimates
• Inhibrx Biosciences (INBX) Reiterated at Market Perform by Citizens on INBRX-106 Ph2 Results